- Home
- CYD vs TARS Comparison
CYD vs TARS Comparison
Compare CYD & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYD
- TARS
- Stock Information
- Founded
- CYD 1951
- TARS 2016
- Country
- CYD Singapore
- TARS United States
- Employees
- CYD N/A
- TARS N/A
- Industry
- CYD Industrial Machinery/Components
- TARS Medicinal Chemicals and Botanical Products
- Sector
- CYD Industrials
- TARS Health Care
- Exchange
- CYD Nasdaq
- TARS Nasdaq
- Market Cap
- CYD 1.5B
- TARS 1.7B
- IPO Year
- CYD 1994
- TARS 2020
- Fundamental
- Price
- CYD $39.45
- TARS $69.50
- Analyst Decision
- CYD
- TARS Strong Buy
- Analyst Count
- CYD 0
- TARS 7
- Target Price
- CYD N/A
- TARS $67.14
- AVG Volume (30 Days)
- CYD 297.6K
- TARS 737.2K
- Earning Date
- CYD 08-08-2025
- TARS 11-12-2025
- Dividend Yield
- CYD 1.33%
- TARS N/A
- EPS Growth
- CYD 40.10
- TARS N/A
- EPS
- CYD 1.66
- TARS N/A
- Revenue
- CYD $3,159,401,156.00
- TARS $295,521,000.00
- Revenue This Year
- CYD $42.20
- TARS $137.28
- Revenue Next Year
- CYD $5.06
- TARS $42.84
- P/E Ratio
- CYD $23.92
- TARS N/A
- Revenue Growth
- CYD 17.99
- TARS 254.45
- 52 Week Low
- CYD $8.61
- TARS $32.91
- 52 Week High
- CYD $42.60
- TARS $69.49
- Technical
- Relative Strength Index (RSI)
- CYD 57.48
- TARS 76.11
- Support Level
- CYD $38.55
- TARS $56.25
- Resistance Level
- CYD $40.98
- TARS $69.47
- Average True Range (ATR)
- CYD 1.71
- TARS 2.43
- MACD
- CYD -0.56
- TARS 1.22
- Stochastic Oscillator
- CYD 30.96
- TARS 95.71
About CYD China Yuchai International Limited
China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.